Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Currency in USD	2025
Operating Income	47.20 Million
Income Before Tax	995.50 Million
Income Tax Expense	235.60 Million
Net Income	759.90 Million
Eps	27.87
Epsdiluted	27.85
Weighted Average Shs Out	27.26 Million
Weighted Average Shs Out Dil	27.28 Million
Research And Development Expenses	275.60 Million
Selling General And Administrative Expenses	844.30 Million
Depreciation And Amortization	165.40 Million
Interest Expense	49.00 Million
Interest Income	95.50 Million
Net Interest Income	46.50 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	1.34 Billion
Ebitda	212.60 Million
Source	edgar
Ebit	1.04 Billion

Bio-Rad Laboratories, Inc. Annual Reports (10-K)